These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 27447710

  • 1. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.
    Pastuszak-Lewandoska D, Kordiak J, Czarnecka KH, Migdalska-Sęk M, Nawrot E, Domańska-Senderowska D, Kiszałkiewicz JM, Antczak A, Górski P, Brzeziańska-Lasota E.
    Med Oncol; 2016 Aug; 33(8):96. PubMed ID: 27447710
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H, Guan X, Tu Y, Zheng S, Long J, Li S, Qi C, Xie X, Zhang H, Zhang Y.
    J Exp Clin Cancer Res; 2015 Jun 11; 34(1):59. PubMed ID: 26063204
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
    Tian G, Wang SW, Song M, Hu YF, Cao XN, Ge JW.
    Eur Rev Med Pharmacol Sci; 2019 Jun 11; 23(12):5260-5269. PubMed ID: 31298377
    [Abstract] [Full Text] [Related]

  • 4. Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
    Kim MK, Jung SB, Kim JS, Roh MS, Lee JH, Lee EH, Lee HW.
    Virchows Arch; 2014 Oct 11; 465(4):463-71. PubMed ID: 25124149
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.
    Lung Cancer; 2013 Sep 11; 81(3):388-396. PubMed ID: 23756108
    [Abstract] [Full Text] [Related]

  • 6. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ, Li XY, Zhao YQ, Liu WJ, Wu HJ, Liu J, Mu XQ, Wu HB.
    Pathol Res Pract; 2017 Aug 11; 213(8):882-888. PubMed ID: 28688608
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB.
    Oncogene; 2011 Jun 09; 30(23):2644-58. PubMed ID: 21358675
    [Abstract] [Full Text] [Related]

  • 8. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.
    Gao L, Yan SB, Yang J, Kong JL, Shi K, Ma FC, Huang LZ, Luo J, Yin SY, He RQ, Hu XH, Chen G.
    BMC Med Genomics; 2020 Jan 06; 13(1):3. PubMed ID: 31906958
    [Abstract] [Full Text] [Related]

  • 9. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 06; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

  • 10. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 06; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 11. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y, Li Y, Wu Q, Deng Y.
    Oncotarget; 2016 Feb 23; 7(8):8441-54. PubMed ID: 26870998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F, Xuan Z, Yang X, Ye X, Pan Z, Fang Q.
    J Cell Biochem; 2020 Mar 23; 121(3):2690-2703. PubMed ID: 31692035
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
    Chen YJ, Guo YN, Shi K, Huang HM, Huang SP, Xu WQ, Li ZY, Wei KL, Gan TQ, Chen G.
    Respir Res; 2019 Mar 04; 20(1):48. PubMed ID: 30832674
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 18. An assessment of the relationship between the expression of CCR7/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer.
    Baran K, Kiszałkiewicz J, Migdalska-Sęk M, Jabłoński S, Kordiak J, Antczak A, Góralska K, Brzeziańska-Lasota E.
    Mol Biol Rep; 2019 Oct 21; 46(5):5389-5396. PubMed ID: 31463641
    [Abstract] [Full Text] [Related]

  • 19. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 21; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW, Wang TB, Tian YH, Zheng YG.
    Int J Clin Exp Pathol; 2015 Jan 21; 8(11):14983-8. PubMed ID: 26823832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.